Literature DB >> 8013430

Cell cycle controls: potential targets for chemical carcinogens?

C A Afshari1, J C Barrett.   

Abstract

The progression of the cell cycle is controlled by the action of both positive and negative growth regulators. The key players in this activity include a family of cyclins and cyclin-dependent kinases, which are themselves regulated by other kinases and phosphatases. Maintenance of balanced cell cycle controls may be directly linked to genomic stability. Loss of the check-points involved in cell cycle control may result in unrepaired DNA damage during DNA synthesis or mitosis leading to genetic mutations and contributing to carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8013430      PMCID: PMC1519451          DOI: 10.1289/ehp.93101s59

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  88 in total

1.  Association of cdk2 kinase with the transcription factor E2F during S phase.

Authors:  M Pagano; G Draetta; P Jansen-Dürr
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

2.  Intracellular localisation and expression of mammalian CDC2 protein during myogenic differentiation.

Authors:  R J Akhurst; N B Flavin; J Worden; M G Lee
Journal:  Differentiation       Date:  1989-03       Impact factor: 3.880

3.  Mitotic arrest and enhanced nuclear protein phosphorylation in human leukemia K562 cells by okadaic acid, a potent protein phosphatase inhibitor and tumor promoter.

Authors:  B Zheng; C F Woo; J F Kuo
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

4.  Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication.

Authors:  T Enoch; P Nurse
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

6.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+.

Authors:  G Draetta; L Brizuela; J Potashkin; D Beach
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

8.  An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins.

Authors:  P Léopold; P H O'Farrell
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  5 in total

1.  Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.

Authors:  Wei Jiang; Jiameng Xu; Zirui Liao; Guangbin Li; Chengpeng Zhang; Yu Feng
Journal:  Front Cell Dev Biol       Date:  2021-03-18

2.  Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.

Authors:  Moran Sun; Minghua Yuan; Yingying Kang; Jinling Qin; Yixin Zhang; Yongtao Duan; Longfei Wang; Yongfang Yao
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

3.  Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene.

Authors:  Jeffrey F Waring; Roger G Ulrich; Nick Flint; David Morfitt; Arno Kalkuhl; Frank Staedtler; Michael Lawton; Johanna M Beekman; Laura Suter
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

Review 4.  Cell proliferation and chemical carcinogenesis: symposium overview.

Authors:  R L Melnick; J Huff; J C Barrett; R R Maronpot; G Lucier; C J Portier
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

5.  Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.

Authors:  Yong-Tao Duan; Ruo-Jun Man; Dan-Jie Tang; Yong-Fang Yao; Xiang-Xiang Tao; Chen Yu; Xin-Yi Liang; Jigar A Makawana; Mei-Juan Zou; Zhong-Chang Wang; Hai-Liang Zhu
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.